Source: Abstracts. Conference titles: Annual Meeting of American Society of Hematology. Unidade: FMRP
Assunto: HEMATOLOGIA
ABNT
SOUZA, Carmino de et al. Allogeneic hematopoietic stem cell transplantation (HSCT): EBMT risk score evaluation for chronic myeloid leukemia in Brazil. 2004, Anais.. San Diego: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2004. . Acesso em: 18 nov. 2024.APA
Souza, C. de, Vigorito, A. C., Ruiz, M. A., Nucci, M., Dulley, F. L., Tabak, D., et al. (2004). Allogeneic hematopoietic stem cell transplantation (HSCT): EBMT risk score evaluation for chronic myeloid leukemia in Brazil. In Abstracts. San Diego: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Souza C de, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Tabak D, Azevedo AM, Byington R, Macedo MCM, Saboya R, Aranha FJP, Oliveira GB, Zulli R, Miranda ECM, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, Souza MP de, Silla L, Bittencourt H, Ruiz LP, Maiolino A, Gratwohl A, Pasquini R. Allogeneic hematopoietic stem cell transplantation (HSCT): EBMT risk score evaluation for chronic myeloid leukemia in Brazil. Abstracts. 2004 ;[citado 2024 nov. 18 ]Vancouver
Souza C de, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Tabak D, Azevedo AM, Byington R, Macedo MCM, Saboya R, Aranha FJP, Oliveira GB, Zulli R, Miranda ECM, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, Souza MP de, Silla L, Bittencourt H, Ruiz LP, Maiolino A, Gratwohl A, Pasquini R. Allogeneic hematopoietic stem cell transplantation (HSCT): EBMT risk score evaluation for chronic myeloid leukemia in Brazil. Abstracts. 2004 ;[citado 2024 nov. 18 ]